The infusion of toll-like receptor 9 (TLR9) agonist-activated macrophages exaggerated disease progression in doxorubicin-induced nephropathy in mice, whereas resting macrophages did not induce disease progression (Wang et al., 2008). This evidence concerns the gene TLR9 and kidney disorder.